Dossier
Chris Shade
Coverage of Chris Shade in the Nexus archive.
- RFK Jr.'s peptide push could become next wellness boom
RFK Jr. advocates for loosening federal restrictions on peptides, potentially boosting telehealth companies, compounding pharmacies, and longevity clinics. The FDA will review peptide regulations in July, while experts debate their efficacy and safety, with market projections reaching $180 billion in five years.